Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) Net Income towards Common Stockholders (2016 - 2025)

HealthLynked (HLYK) has disclosed Net Income towards Common Stockholders for 10 consecutive years, with -$530894.0 as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders rose 29.1% to -$530894.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.1 million through Dec 2025, up 54.82% year-over-year, with the annual reading at -$2.1 million for FY2025, 54.82% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was -$530894.0 at HealthLynked, roughly flat from -$529586.0 in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $1.5 million in Q1 2023, with the low at -$7.9 million in Q1 2021.
  • Average Net Income towards Common Stockholders over 5 years is -$1.4 million, with a median of -$1.0 million recorded in 2023.
  • The sharpest move saw Net Income towards Common Stockholders tumbled 1263.6% in 2021, then soared 215.55% in 2023.
  • Over 5 years, Net Income towards Common Stockholders stood at -$1.8 million in 2021, then crashed by 141.85% to -$4.4 million in 2022, then soared by 70.53% to -$1.3 million in 2023, then skyrocketed by 41.76% to -$748774.0 in 2024, then increased by 29.1% to -$530894.0 in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at -$530894.0, -$529586.0, and -$435385.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.